Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$1,039.11 USD
-6.26 (-0.60%)
Updated Jun 18, 2024 04:00 PM ET
After-Market: $1,038.41 -0.70 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $10.57 | -9.28% |
Earnings Summary
For their last quarter, Regeneron Pharmaceuticals (REGN) reported earnings of $9.55 per share, missing the Zacks Consensus Estimate of $10.20 per share. This reflects a negative earnings surprise of 6.37%. Look out for REGN's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $10.57 per share, reflecting a year-over-year increase of 3.22%.
Earnings History
Price & Consensus
Zacks News for REGN
Intellia (NTLA) Banks on Genome Editing Pipeline Amid Rivalry
REGN: What are Zacks experts saying now?
Zacks Private Portfolio Services